Literature DB >> 10935648

Dedifferentiated clear cell chondrosarcoma.

R K Kalil1, C Y Inwards, K K Unni, F Bertoni, P Bacchini, D E Wenger, F H Sim.   

Abstract

Dedifferentiation, a change in the histologic character and clinical behavior of a tumor to a more immature and aggressive one, occurs in approximately 11% of all chondrosarcomas. The original lesion is usually a low-grade chondrosarcoma. Clear cell chondrosarcoma is a rare cartilaginous tumor of low-grade malignancy with a preference for the ends of long bones. It is usually curable by resection. Recurrence commonly follows inadequate surgery, and metastases to lung, brain, and bones can develop. However, dedifferentiation has not yet been described in association with clear cell chondrosarcoma. Three patients are described who were initially diagnosed as having clear cell chondrosarcoma of the femur. Two were treated with en bloc resection for a clear cell chondrosarcoma. One of these had an undifferentiated sarcoma in a local recurrence after 6 years. In the second, metastasis of the clear cell chondrosarcoma developed 5(1/2) years after surgery; autopsy revealed undifferentiated sarcoma in the lung, heart, and lumbar spine. The third patient had dedifferentiated clear cell chondrosarcoma at the time of resection following the biopsy diagnosis of clear cell chondrosarcoma. All three died with metastatic disease. These three patients represent three different manifestations of dedifferentiation-at initial diagnosis, at recurrence, and at metastasis. To our knowledge, this is the first description of dedifferentiation occurring in clear cell chondrosarcoma.

Entities:  

Mesh:

Year:  2000        PMID: 10935648     DOI: 10.1097/00000478-200008000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

Review 1.  The imaging of cartilaginous bone tumours. II. Chondrosarcoma.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-10-04       Impact factor: 2.199

2.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

3.  Giant-sized primary clear cell chondrosarcoma of the thoracolumbar spine: A very rare case report.

Authors:  Fachrisal Ipang; Didik Librianto; Dina Aprilya; Bonita Prawirodihardjo
Journal:  Ann Med Surg (Lond)       Date:  2021-12-06

4.  Clear Cell Chondrosarcoma-Oncological Outcomes in an Asian Cohort.

Authors:  Ashish Gulia; Vineet Kurisunkal; Ajay Puri; Prakash Nayak; Bharat Rekhi
Journal:  Indian J Surg Oncol       Date:  2021-09-16

5.  Chondrosarcoma cell differentiation.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  2004-09-25       Impact factor: 3.201

6.  Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma.

Authors:  T De Coninck; L Jans; G Sys; W Huysse; T Verstraeten; R Forsyth; B Poffyn; K Verstraete
Journal:  Eur Radiol       Date:  2013-06-17       Impact factor: 5.315

7.  Clear cell chondrosarcoma: radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation.

Authors:  Mark S Collins; Takashi Koyama; Ronald G Swee; Carrie Y Inwards
Journal:  Skeletal Radiol       Date:  2003-10-07       Impact factor: 2.199

8.  Clear cell chondrosarcoma with secondary aneurysmal bone cyst changes.

Authors:  Timothy Tay; Steven Bak Siew Wong; Kesavan so Sittampalam; Denny Tjiauw Tjoen Lie
Journal:  Singapore Med J       Date:  2014-03       Impact factor: 1.858

9.  Chondrosarcoma: with updates on molecular genetics.

Authors:  Mi-Jung Kim; Kyung-Ja Cho; Alberto G Ayala; Jae Y Ro
Journal:  Sarcoma       Date:  2011-02-15

10.  Primary clear cell chondrosarcoma of the spine: a case report of a rare entity and a review of the literature.

Authors:  Nikolaos A Paidakakos; Aristides Rovlias; Evaggelos Rokas; Spyridon Theodoropoulos; Patroklos Katafygiotis
Journal:  Case Rep Oncol Med       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.